Emergências e Terapia Intensiva
Breve revisão | Monitoramento da dor na unidade de terapia intensiva.
2 Ago, 2022 | 13:25hMonitoring pain in the intensive care unit (ICU) – Intensive Care Medicine (se o acesso a este link for pago, tente este)
Comentário no Twitter
Monitoring pain in #ICU
➡️ self‐assessment tools in pts able to self‐report
➡️ observational behavioural scales in pts unable to self‐report
➡️ physiologic parameters in pts unable to self‐report nor express behaviours (deep sedaution, NMBAs)#FOAMcc
🖇 https://t.co/SaD1BBxSNw pic.twitter.com/81tNNvnTDe— Intensive Care Medicine (@yourICM) July 30, 2022
M-A | Probióticos na doença crítica.
2 Ago, 2022 | 13:23hProbiotics in Critical Illness: A Systematic Review and Meta-Analysis of Randomized Controlled Trials – Critical Care Medicine (gratuito por tempo limitado)
Comentário no Twitter
#OpenAccess #VisualAbstract @SameerSharifMD et al: Sys Review & MA of #Probiotics in #CritCareMed
67 RCTs 8483 pts
⬇️VAP HAP #ICULOS, #mechvent
No effect on mortality
Low certainty evidenceLink: https://t.co/kN7FliTpbr@SCCM #CritCareMed @Bram_Rochwerg @leashgreer pic.twitter.com/pROjhq9T2J
— Critical Care Medicine (@CritCareMed) July 22, 2022
M-A | Estratégia de suporte respiratório em adultos com insuficiência respiratória hipoxêmica aguda.
2 Ago, 2022 | 13:15h
Estudo de coorte | Análise de prescrições para terapia antiplaquetária dupla após AVC isquêmico agudo.
1 Ago, 2022 | 15:09hConteúdos relacionados:
Comentário no Twitter
In this cohort study, dual antiplatelet of aspirin and clopidogrel was underused in patients with minor ischemic stroke and potentially overused in non-minor ischemic stroke, with substantial hospital variations. https://t.co/rZeGbMgF1E
— JAMA Network Open (@JAMANetworkOpen) July 28, 2022
Revisão | Exames de imagem na síndrome da angústia respiratória aguda: passado, presente e futuro.
18 Jul, 2022 | 13:38hImaging the acute respiratory distress syndrome: past, present and future – Intensive Care Medicine
Comentário no Twitter
Imaging #ARDS: past, present & future
➡️ physiopathology
➡️ management: PEEP/recruitment; inflation (& hyperinfation)
➡️ effects of proning on ventilation/perfusion
➡️ lung infammation
➡️ #COVID19
➡️ identifying complications
➡️ prognostication
& more!
📎 https://t.co/tEp50muK8J pic.twitter.com/GlME1vTePh— Intensive Care Medicine (@yourICM) July 14, 2022
Estudo randomizado | Tixagevimabe-cilgavimabe para tratamento de pacientes internados com COVID-19.
18 Jul, 2022 | 13:36hComentário: The potential of tixagevimab–cilgavimab for treating hospitalized COVID-19 patients – News Medical
Conteúdos relacionados:
Comentário no Twitter
In pts hospitalised w/ COVID-19 receiving remdesivir and other standard care, tixagevimab–cilgavimab did not improve time to sustained recovery but was safe and mortality was lower vs placebo
From the ACTIV-3–TICO Study Group https://t.co/zaaXBQYl5t pic.twitter.com/xe0tmbFrZ9
— The Lancet Respiratory Medicine (@LancetRespirMed) July 11, 2022
Revisão | Infecções fúngicas respiratórias invasivas em pacientes críticos com COVID-19.
18 Jul, 2022 | 13:33hInvasive Respiratory Fungal Infections in COVID-19 Critically Ill Patients – Journal of Fungi
M-A (maioria de estudos observacionais) | Trombólise guiada por cateter vs. anticoagulação sistêmica isolada para embolia pulmonar submaciça.
18 Jul, 2022 | 13:20h
Revisão | Suporte circulatório mecânico temporário: dispositivos, desfechos e direções futuras.
18 Jul, 2022 | 12:37h
Estudo randomizado | Trombectomia endovascular isoladamente NÃO é não inferior à ponte trombolítica padrão associada a trombectomia endovascular dentro de 4,5 horas do início do AVC.
14 Jul, 2022 | 12:05hEndovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial – The Lancet (link para o resumo – $ para o texto completo)
Estudo relacionado: Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial – The Lancet (link para o resumo – $ para o texto completo)
Comentário no Twitter
Two new RCTs show we shouldn't skip bridging intravenous thrombolysis in eligible thrombectomy patients: DIRECT-SAFE (n=293) & SWIFT DIRECT (n=408) @TheLancet @SNISinfo@cvsection https://t.co/Tks14TlaVFhttps://t.co/WaTPn34diy pic.twitter.com/Gcddws8oDf
— Babak Jahromi MD PhD FRCSC (@babaksjahromi) July 9, 2022


